Association between menarche age and menstrual disorder with the incidence of uterine fibroid in medan, Indonesia: based on hospital data

Authors

  • Muhammad Fidel Ganis Siregar Division of Reproductive Endocrinology and Fertility, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Sumatera Utara

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20150420

Keywords:

Menarche age, Menstrual disorder, Uterine fibroid

Abstract

Background: Uterine fibroids are benign, monoclonal tumors of the smooth muscle cells found in the human uterus. The incidence of uterine fibroid in Indonesia is between 2.39% - 11.7% in all gynecology inpatient. Despite the fact that their cause is still unknown, there is considerable evidence that estrogens and progestogens proliferate tumor growth, as the fibroids rarely appear before menarche and regress after menopause.

Methods: An observational analytic study with case control approach. Total sample from this study was 498 people, with 249 cases and 249 controls. The samples were collected through purposive sampling. The study was conducted in the medical record division of Adam Malik General Hospital Medan. Results from the study were analyzed with chi square.

Results: The result of this study demonstrated an association between menarche age with uterine fibroid incidence, with a p-value < 0.05, and odds ratio = 2.487 (CI 1.585-3.902). This indicate that the incidence of uterine fibroid is 2.5 greater in women with menarche age of < 10 years old. P-value < 0.05 and odds ratio = 0.258 (CI 0.178-0.375) were obtained from the association between menstrual disorder and uterine fibroid incidence.

Conclusions: The result of this study demonstrates a significant association correlation between menarche age and the development of uterine fibroid. Early menarche age increases risk of uterine fibroid incidence, whereas menstrual disorder is more likely a clinical manifestation of uterine fibroid, rather than a risk factor.

References

Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril. 2007;87(4):725-36.

Kempson RL, Hendrickson MR. Smooth muscle, endometrial stromal, and mixed Müllerian tumors of the uterus. Mod Pathol. 2000;13(3):328-42.

Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. Am J Obstet Gynecol. 1995;172(1 Pt1):14-8.

Andersen J. Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol. 1996;14(3):269-82.

Fields KR, Neinstein LS. Uterine myomas in adolescents: case reports and a review of the literature. J Pediatr Adolesc Gynecol. 1996;9(4):195-8.

Cramer SF, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol. 1990;94(4):435-8.

Farquhar CM, Steiner CA: Hysterectomy rates in the United States 1990- 1997. Obstet Gynecol. 2002;99(2):229-34.

Merrill RM: Hysterectomy surveillance in the United States, 1997 through 2005. Med Sci Monit. 2008;14(1):CR24-CR31.

Laughlin SK, Schroeder JC, Baird DD. New directions in the epidemiology of uterine fibroids. Semin Reprod Med. 2010, 28(3):204-17.

Laughlin SK, Baird DD, Savitz DA, Herring AH, Hartmann KE. Prevalence of uterine leiomyomas in the first trimester of pregnancy: an ultrasound screening study. Obstet Gynecol. 2009;113(3):630-5.

Chen CR, Buck GM, Courey NG, Perez KM, Wactawski-Wende J. Risk factors for uterine fibroids among women undergoing tubal sterilization. Am J Epidemiol. 2001;153(1):20-6.

Borgfeldt C, Andolf E: Transvaginal ultrasonographic findings in the uterus and the endometrium: low prevalence of leiomyoma in a random sample of women age 25-40 years. Acta Obstet Gynecol Scand. 2000;79(3):202-7.

Marino JL, Eskenazi B, Warner M, Samuels S, Vercellini P, Gavoni N, et al. Uterine leiomyoma and menstrual cycle characteristics in a population based cohort study. Hum Reprod. 2004;19(10):2350-5.

Parazzini F, Negri E, La Vecchia C, Chatenoud L, Ricci E, Guarnerio P. Reproductive factors and risk of uterine fibroids. Epidemiology. 19967(4):440-2.

Parazzini F. Risk factors for clinically diagnosed uterine fibroids in women around menopause. Maturitas. 2006;55(2):174-9.

Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot medroxyprogesterone acetate on surgically treated uterine leiomyomas:a multicentre case-control study. Br J Obstet Gynaecol. 1996;103(9):909-14.

Schwartz SM, Marshall LM, Baird DD. Epidemiologic contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect. 2000;108(Suppl 5):821-7.

Okolo S. Incidence, aetiology and epidemiology of uterine fibroids. Best Pract Res Clin Obstet Gynaecol. 2008;22(4):571-88.

Ryan GL, Syrop CH, Van Voorhis BJ. Role, epidemiology, and natural history of benign uterine mass lesions. Clin Obstet Gynecol. 2005;48(2):312-24.

Chavarro J, Villamor E, Narvaez J, et al. Socio-demographic predictors of age at menarche in a group of Colombian university women. Ann Hum Biol. 2004;31(2):245–57.

de Vries MJ, Dekker GA, Schoemaker J. Higher risk of preeclampsia in the polycystic ovary syndrome. A case control study. Eur J Obstet Gynecol Reprod Biol. 1998;76(1):91–5.

Freedman DS, Khan LK, Serdula MK, et al. The relation of menarcheal age to obesity in childhood and adulthood: the Bogalusa heart study. BMC Pediatr. 2003;3:3.

Lakshman R, Forouhi NG, Sharp SJ, et al. Early age at menarche associated with cardiovascular disease and mortality. J Clin Endocrinol Metab. 2009;94(12):4953–60.

Rudra CL, Williams MA. BMI as a modifying factor in the relations between age at menarche, menstrual cycle characteristics, and risk of preeclampsia. Gynecol Endocrinol. 2005;21(4):200–5.

Solomon CG, Hu FB, Dunaif A, et al. Menstrual cycle irregularity and risk for future cardiovascular disease. J Clin Endocrinol Metab. 2002;87(5):2013-7.

Veltman-Verhulst SM, van Rijn BB,Westerveld HE, et al. Polycystic ovary syndrome and early-onset preeclampsia: reproductive manifestations of increased cardiovascular risk. Menopause. 2010;17(5):990–6.

Abetew DF, Enquobahrie DA, Dishi M, et al. Age at menarche, menstrual characteristics, and risk of preeclampsia. ISRN Obstet Gynecol. 2011;2011: 472083.

MacMahon B, Trichopoulos D, Brown J, et al. Age at menarche, urine estrogens and breast cancer risk. Int J Cancer. 1982;30(4):427–31.

Pieta B, Chmaj-Wierzchowska K, Opala T. Past obstetric history and risk of ovarian cancer. Ann Agric Environ Med. 2012;19(3):385–8.

Dragomir AD, Schroeder JC, Connolly A, et al. Potential risk factors associated with subtypes of uterine leiomyomata. Reprod Sci. 2010;17(11):1029–35.

Wise LA, Palmer JR, Harlow BL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study. Am J Epidemiol. 2004;159(2):113–23.

Faerstein E, Szklo M, Rosenshein N. Risk factors for uterine leiomyoma: a practice-based case-control study. I. African-American heritage, reproductive history, body size, and smoking. Am J Epidemiol. 2001;153(1):1–10.

Lumbiganon P, Rugpao S, Phandhu-fung S, et al. Protective effect of depot-medroxyprogesterone acetate on surgically treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol. 1996;103(9):909–14.

Marshall LM, Spiegelman D, Goldman MB, et al. A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata. Fertil Steril. 1998;70(3):432–9.

Samadi AR, Lee NC, Flanders WD, et al. Risk factors for self-reported uterine fibroids: a case-control study. Am J Public Health. 1996;86(6):858–62.

Muzakir. Profil Penderita Mioma Uteri di RSUD Arifin Achmad Provinsi Riau Periode 1 Januari-31 Desember 2006. Faculty of Medicine – University Riau; 2008.

Downloads

Published

2017-02-09

Issue

Section

Original Research Articles